{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:14:31Z","timestamp":1790799271466,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["CRO Aviano Ricerca Corrente core grant"],"award-info":[{"award-number":["CRO Aviano Ricerca Corrente core grant"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["CO-2018-12367051"],"award-info":[{"award-number":["CO-2018-12367051"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2016-02361041"],"award-info":[{"award-number":["GR-2016-02361041"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006601","name":"Ministero degli Affari Esteri e della Cooperazione Internazionale","doi-asserted-by":"publisher","award":["PGR01036"],"award-info":[{"award-number":["PGR01036"]}],"id":[{"id":"10.13039\/501100006601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["ARS01_00568"],"award-info":[{"award-number":["ARS01_00568"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG 26253"],"award-info":[{"award-number":["IG 26253"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["IG 20061"],"award-info":[{"award-number":["IG 20061"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"Fondazione AIRC per la ricerca sul cancro ETS","doi-asserted-by":"publisher","award":["MFAG 24321"],"award-info":[{"award-number":["MFAG 24321"]}],"id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CRO-Aviano 5X1000 grants","award":["Cancer Specific"],"award-info":[{"award-number":["Cancer Specific"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Platinum (PT)-resistant Epithelial Ovarian Cancer (EOC) grows as a metastatic disease, disseminating in the abdomen and pelvis. Very few options are available for PT-resistant EOC patients, and little is known about how the acquisition of PT-resistance mediates the increased spreading capabilities of EOC. Here, using isogenic PT-resistant cells, genetic and pharmacological approaches, and patient-derived models, we report that Integrin \u03b16 (ITGA6) is overexpressed by PT-resistant cells and is necessary to sustain EOC metastatic ability and adhesion-dependent PT-resistance. Using in vitro approaches, we showed that PT induces a positive loop that, by stimulating ITGA6 transcription and secretion, contributes to the formation of a pre-metastatic niche enabling EOC cells to disseminate. At molecular level, ITGA6 engagement regulates the production and availability of insulin-like growth factors (IGFs), over-stimulating the IGF1R pathway and upregulating Snail expression. In vitro data were recapitulated using in vivo models in which the targeting of ITGA6 prevents PT-resistant EOC dissemination and improves PT-activity, supporting ITGA6 as a promising druggable target for EOC patients.<\/jats:p>","DOI":"10.1038\/s44321-024-00069-3","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T06:01:49Z","timestamp":1713938509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Platinum-induced upregulation of ITGA6 promotes chemoresistance and spreading in ovarian cancer"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0223-9798","authenticated-orcid":false,"given":"Alice","family":"Gambelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nespolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0739-1668","authenticated-orcid":false,"given":"Gian Luca","family":"Rampioni Vinciguerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Pivetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Pellarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena S","family":"Nicoloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Scapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Stefenatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Segatto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Mucignat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bartoletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6882-5613","authenticated-orcid":false,"given":"Emilio","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4804-4291","authenticated-orcid":false,"given":"Monica","family":"Schiappacassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3033-404X","authenticated-orcid":false,"given":"Paola","family":"Spessotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Canzonieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5497-6856","authenticated-orcid":false,"given":"Andrea","family":"Vecchione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2249-0285","authenticated-orcid":false,"given":"Barbara","family":"Belletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9505-9771","authenticated-orcid":false,"given":"Maura","family":"Sonego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9750-8825","authenticated-orcid":false,"given":"Gustavo","family":"Baldassarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,24]]},"reference":[{"key":"69_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.2174\/156800910791190175","volume":"10","author":"N Ahmed","year":"2010","unstructured":"Ahmed N, Abubaker K, Findlay J, Quinn M (2010) Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets 10:268\u2013278","journal-title":"Curr Cancer Drug Targets"},{"key":"69_CR2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10585-005-1262-y","volume":"22","author":"N Ahmed","year":"2005","unstructured":"Ahmed N, Riley C, Rice G, Quinn M (2005) Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis 22:391\u2013402","journal-title":"Clin Exp Metastasis"},{"key":"69_CR3","doi-asserted-by":"publisher","first-page":"112815","DOI":"10.1016\/j.yexcr.2021.112815","volume":"407","author":"JS An","year":"2021","unstructured":"An JS, Moon JH, Kim C, No JK, Eun YG, Chang Lim Y (2021) Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma. Exp Cell Res 407:112815","journal-title":"Exp Cell Res"},{"key":"69_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12079-015-0288-4","volume":"9","author":"LA Bach","year":"2015","unstructured":"Bach LA (2015) Recent insights into the actions of IGFBP-6. J Cell Commun Signal 9:189\u2013200","journal-title":"J Cell Commun Signal"},{"key":"69_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1083\/jcb.200409067","volume":"168","author":"RE Bachelder","year":"2005","unstructured":"Bachelder RE, Yoon S-O, Franci C, de Herreros AG, Mercurio AM (2005) Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 168:29\u201333","journal-title":"J Cell Biol"},{"key":"69_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ccr.2004.11.025","volume":"7","author":"G Baldassarre","year":"2005","unstructured":"Baldassarre G, Belletti B, Nicoloso MS, Schiappacassi M, Vecchione A, Spessotto P, Morrione A, Canzonieri V, Colombatti A (2005) p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion. Cancer Cell 7:51\u201363","journal-title":"Cancer Cell"},{"key":"69_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/978-0-387-98094-2_15","volume":"149","author":"MV Barbolina","year":"2009","unstructured":"Barbolina MV, Moss NM, Westfall SD, Liu Y, Burkhalter RJ, Marga F, Forgacs G, Hudson LG, Stack MS (2009) Microenvironmental regulation of ovarian cancer metastasis. Cancer Treat Res 149:319\u2013334","journal-title":"Cancer Treat Res"},{"key":"69_CR8","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1074\/jbc.M113.515254","volume":"289","author":"S Basu","year":"2014","unstructured":"Basu S, Rajakaruna S, De Arcangelis A, Zhang L, Georges-Labouesse E, Menko AS (2014) \u03b16 integrin transactivates insulin-like growth factor receptor-1 (IGF-1R) to regulate caspase-3-mediated lens epithelial cell differentiation initiation. J Biol Chem 289:3842\u20133855","journal-title":"J Biol Chem"},{"key":"69_CR9","doi-asserted-by":"publisher","first-page":"863850","DOI":"10.3389\/fcell.2022.863850","volume":"10","author":"C Bergonzini","year":"2022","unstructured":"Bergonzini C, Kroese K, Zweemer AJM, Danen EHJ (2022) Targeting integrins for cancer therapy - disappointments and opportunities. Front Cell Dev Biol 10:863850","journal-title":"Front Cell Dev Biol"},{"key":"69_CR10","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1177\/00220345010800080601","volume":"80","author":"KC Bhol","year":"2001","unstructured":"Bhol KC, Goss L, Kumari S, Colon JE, Ahmed AR (2001) Autoantibodies to human alpha6 integrin in patients with oral pemphigoid. J Dent Res 80:1711\u20131715","journal-title":"J Dent Res"},{"key":"69_CR11","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2174\/1574888X13666181002151330","volume":"14","author":"GD Bigoni-Ord\u00f3\u00f1ez","year":"2019","unstructured":"Bigoni-Ord\u00f3\u00f1ez GD, Czarnowski D, Parsons T, Madlambayan GJ, Villa-Diaz LG (2019) Integrin \u03b16 (CD49f), the microenvironment and cancer stem cells. Curr Stem Cell Res Ther 14:428\u2013436","journal-title":"Curr Stem Cell Res Ther"},{"key":"69_CR12","doi-asserted-by":"publisher","first-page":"e0184285","DOI":"10.1371\/journal.pone.0184285","volume":"12","author":"DM Cedano Prieto","year":"2017","unstructured":"Cedano Prieto DM, Cheng Y, Chang C-C, Yu J, Takada YK, Takada Y (2017) Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling. PLoS ONE 12:e0184285","journal-title":"PLoS ONE"},{"key":"69_CR13","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012872","volume":"13","author":"F Citron","year":"2021","unstructured":"Citron F, Segatto I, Musco L, Pellarin I, Rampioni Vinciguerra GL, Franchin G, Fanetti G, Miccich\u00e8 F, Giacomarra V, Lupato V et al (2021) miR-9 modulates and predicts the response to radiotherapy and EGFR inhibition in HNSCC. EMBO Mol Med 13:e12872","journal-title":"EMBO Mol Med"},{"key":"69_CR14","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1182\/blood.V93.5.1658","volume":"93","author":"JS Damiano","year":"1999","unstructured":"Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, Dalton WS (1999) Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 93:1658\u20131667","journal-title":"Blood"},{"key":"69_CR15","doi-asserted-by":"publisher","first-page":"166282","DOI":"10.1016\/j.bbadis.2021.166282","volume":"1868","author":"AN Deo","year":"2022","unstructured":"Deo AN, Thorat R, Dhadve AC, De A, Rekhi B, Ray P (2022) IGF1R-\u03b16 integrin-S100A4 network governs the organ-specific metastasis of chemoresistant epithelial ovarian cancer cells. Biochim Biophys Acta (BBA) - Mol Basis Dis 1868:166282","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"69_CR16","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10585-021-10136-5","volume":"39","author":"D Dhaliwal","year":"2022","unstructured":"Dhaliwal D, Shepherd TG (2022) Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review. Clin Exp Metastasis 39:291\u2013301","journal-title":"Clin Exp Metastasis"},{"key":"69_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/bs.acr.2020.04.005","volume":"147","author":"LM Fettig","year":"2020","unstructured":"Fettig LM, Yee D (2020) Advances in insulin-like growth factor biology and -directed cancer therapeutics. Adv Cancer Res 147:229\u2013257","journal-title":"Adv Cancer Res"},{"key":"69_CR18","doi-asserted-by":"publisher","first-page":"12491","DOI":"10.1074\/jbc.M111.304170","volume":"287","author":"M Fujita","year":"2012","unstructured":"Fujita M, Ieguchi K, Davari P, Yamaji S, Taniguchi Y, Sekiguchi K, Takada YK, Takada Y (2012) Cross-talk between integrin \u03b16\u03b24 and insulin-like growth factor-1 receptor (IGF1R) through direct \u03b16\u03b24 binding to IGF1 and subsequent \u03b16\u03b24-IGF1-IGF1R ternary complex formation in anchorage-independent conditions. J Biol Chem 287:12491\u201312500","journal-title":"J Biol Chem"},{"key":"69_CR19","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1182\/blood.2019001417","volume":"136","author":"EJ Gang","year":"2020","unstructured":"Gang EJ, Kim HN, Hsieh Y-T, Ruan Y, Ogana HA, Lee S, Pham J, Geng H, Park E, Klemm L et al (2020) Integrin \u03b16 mediates the drug resistance of acute lymphoblastic B-cell leukemia. Blood 136:210\u2013223","journal-title":"Blood"},{"key":"69_CR20","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1167\/iovs.07-0016","volume":"48","author":"M Gaudreault","year":"2007","unstructured":"Gaudreault M, Vigneault F, Leclerc S, Gu\u00e9rin SL (2007) Laminin reduces expression of the human alpha6 integrin subunit gene by altering the level of the transcription factors Sp1 and Sp3. Invest Ophthalmol Vis Sci 48:3490\u20133505","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"69_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/cancers10020042","volume":"10","author":"J-F Groulx","year":"2018","unstructured":"Groulx J-F, Boudjadi S, Beaulieu J-F (2018) MYC regulates \u03b16 integrin subunit expression and splicing under its pro-proliferative ITGA6A form in colorectal cancer cells. Cancers 10:42","journal-title":"Cancers"},{"key":"69_CR22","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1021\/pr900411g","volume":"8","author":"CG Gunawardana","year":"2009","unstructured":"Gunawardana CG, Kuk C, Smith CR, Batruch I, Soosaipillai A, Diamandis EP (2009) Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer. J Proteome Res 8:4705\u20134713","journal-title":"J Proteome Res"},{"key":"69_CR23","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1007\/s11357-023-00742-4","volume":"45","author":"B Gy\u0151rffy","year":"2023","unstructured":"Gy\u0151rffy B (2023) Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer. Geroscience 45:1889\u20131898","journal-title":"Geroscience"},{"key":"69_CR24","doi-asserted-by":"publisher","first-page":"56","DOI":"10.4161\/cam.21831","volume":"7","author":"E Hohenester","year":"2013","unstructured":"Hohenester E, Yurchenco PD (2013) Laminins in basement membrane assembly. Cell Adhes Migr 7:56\u201363","journal-title":"Cell Adhes Migr"},{"key":"69_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/nature15756","volume":"527","author":"A Hoshino","year":"2015","unstructured":"Hoshino A, Costa-Silva B, Shen T-L, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S et al (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527:329\u2013335","journal-title":"Nature"},{"key":"69_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/j.1365-2184.2005.00344.x","volume":"38","author":"X Huang","year":"2005","unstructured":"Huang X, Halicka HD, Traganos F, Tanaka T, Kurose A, Darzynkiewicz Z (2005) Cytometric assessment of DNA damage in relation to cell cycle phase and apoptosis. Cell Prolif 38:223\u2013243","journal-title":"Cell Prolif"},{"key":"69_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes RO (2002) Integrins: bidirectional, allosteric signaling machines. Cell 110:673\u2013687","journal-title":"Cell"},{"key":"69_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8419","volume":"6","author":"TA Ince","year":"2015","unstructured":"Ince TA, Sousa AD, Jones MA, Harrell JC, Agoston ES, Krohn M, Selfors LM, Liu W, Chen K, Yong M et al (2015) Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours. Nat Commun 6:7419","journal-title":"Nat Commun"},{"key":"69_CR29","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","volume":"384","author":"GC Jayson","year":"2014","unstructured":"Jayson GC, Kohn EC, Kitchener HC, Ledermann JA (2014) Ovarian cancer. Lancet 384:1376\u20131388","journal-title":"Lancet"},{"key":"69_CR30","doi-asserted-by":"publisher","first-page":"10914","DOI":"10.1128\/JVI.01208-07","volume":"81","author":"G Jiang","year":"2007","unstructured":"Jiang G, Espeseth A, Hazuda DJ, Margolis DM (2007) c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J Virol 81:10914\u201310923","journal-title":"J Virol"},{"key":"69_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.ygyno.2022.10.010","volume":"167","author":"SI Kim","year":"2022","unstructured":"Kim SI, Kim JH, Lee S, Cho H, van Driel WJ, Sonke GS, Bristow RE, Park S-Y, Fotopoulou C, Lim MC (2022) Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: a meta-analysis. Gynecol Oncol 167:547\u2013556","journal-title":"Gynecol Oncol"},{"key":"69_CR32","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1089\/scd.2016.0319","volume":"26","author":"PH Krebsbach","year":"2017","unstructured":"Krebsbach PH, Villa-Diaz LG (2017) The role of integrin \u03b16 (CD49f) in stem cells: more than a conserved biomarker. Stem Cells Dev 26:1090\u20131099","journal-title":"Stem Cells Dev"},{"key":"69_CR33","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.3390\/life12121992","volume":"12","author":"J-S Lee","year":"2022","unstructured":"Lee J-S, Tocheny CE, Shaw LM (2022) The insulin-like growth factor signaling pathway in breast cancer: an elusive therapeutic target. Life 12:1992","journal-title":"Life"},{"key":"69_CR34","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","volume":"393","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Gourley C, Vergote I, Oza AM (2019) Epithelial ovarian cancer. Lancet 393:1240\u20131253","journal-title":"Lancet"},{"key":"69_CR35","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s13402-019-00486-4","volume":"43","author":"X Li","year":"2020","unstructured":"Li X, Tang M, Zhu Q, Wang X, Lin Y, Wang X (2020) The exosomal integrin \u03b15\u03b21\/AEP complex derived from epithelial ovarian cancer cells promotes peritoneal metastasis through regulating mesothelial cell proliferation and migration. Cell Oncol 43:263\u2013277","journal-title":"Cell Oncol"},{"key":"69_CR36","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ctrv.2017.08.012","volume":"60","author":"JAL Liefers-Visser","year":"2017","unstructured":"Liefers-Visser JAL, Meijering RAM, Reyners AKL, van der Zee AGJ, de Jong S (2017) IGF system targeted therapy: therapeutic opportunities for ovarian cancer. Cancer Treat Rev 60:90\u201399","journal-title":"Cancer Treat Rev"},{"key":"69_CR37","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1089\/dna.1997.16.929","volume":"16","author":"CS Lin","year":"1997","unstructured":"Lin CS, Chen Y, Huynh T, Kramer R (1997) Identification of the human alpha6 integrin gene promoter. DNA Cell Biol 16:929\u2013937","journal-title":"DNA Cell Biol"},{"key":"69_CR38","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ccell.2021.01.013","volume":"39","author":"Y-H Lin","year":"2021","unstructured":"Lin Y-H, Zhu H (2021) A malignant case of arrested development: cancer cell dormancy mimics embryonic diapause. Cancer Cell 39:142\u2013144","journal-title":"Cancer Cell"},{"key":"69_CR39","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1369\/jhc.4A6597.2005","volume":"53","author":"M M\u00e4\u00e4tt\u00e4","year":"2005","unstructured":"M\u00e4\u00e4tt\u00e4 M, B\u00fctzow R, Luostarinen J, Pet\u00e4j\u00e4niemi N, Pihlajaniemi T, Salo S, Miyazaki K, Autio-Harmainen H, Virtanen I (2005) Differential expression of laminin isoforms in ovarian epithelial carcinomas suggesting different origin and providing tools for differential diagnosis. J Histochem Cytochem 53:1293\u20131300","journal-title":"J Histochem Cytochem"},{"key":"69_CR40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0955-0674(00)00249-0","volume":"13","author":"AM Mercurio","year":"2001","unstructured":"Mercurio AM, Rabinovitz I, Shaw LM (2001) The alpha 6 beta 4 integrin and epithelial cell migration. Curr Opin Cell Biol 13:541\u2013545","journal-title":"Curr Opin Cell Biol"},{"key":"69_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19584-1","volume":"11","author":"S Naffar-Abu Amara","year":"2020","unstructured":"Naffar-Abu Amara S, Kuiken HJ, Selfors LM, Butler T, Leung ML, Leung CT, Kuhn EP, Kolarova T, Hage C, Ganesh K et al (2020) Transient commensal clonal interactions can drive tumor metastasis. Nat Commun 11:5799","journal-title":"Nat Commun"},{"key":"69_CR42","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1006\/bbrc.1997.7808","volume":"241","author":"K Nishida","year":"1997","unstructured":"Nishida K, Kitazawa R, Mizuno K, Maeda S, Kitazawa S (1997) Identification of regulatory elements of human alpha 6 integrin subunit gene. Biochem Biophys Res Commun 241:258\u2013263","journal-title":"Biochem Biophys Res Commun"},{"key":"69_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0273-7","volume":"16","author":"CR Oliva","year":"2018","unstructured":"Oliva CR, Halloran B, Hjelmeland AB, Vazquez A, Bailey SM, Sarkaria JN, Griguer CE (2018) IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2\/IGF-1R signaling. Cell Commun Signal 16:61","journal-title":"Cell Commun Signal"},{"key":"69_CR44","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00404-013-2715-1","volume":"287","author":"A Papadia","year":"2013","unstructured":"Papadia A, Morotti M (2013) Diaphragmatic surgery during cytoreduction for primary or recurrent epithelial ovarian cancer: a review of the literature. Arch Gynecol Obstet 287:733\u2013741","journal-title":"Arch Gynecol Obstet"},{"key":"69_CR45","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3892\/ol.2022.13305","volume":"23","author":"A Piscazzi","year":"2022","unstructured":"Piscazzi A, Condelli V, Crispo F, Coda ARD, Calice G, Bruno G, Venuto S, Tibullo D, Giordano G, Pietrafesa M et al (2022) Differential and divergent activity of insulin-like growth factor binding protein 6 in platinum-sensitive versus platinum-resistant high-grade serous ovarian carcinoma cell lines. Oncol Lett 23:185","journal-title":"Oncol Lett"},{"key":"69_CR46","doi-asserted-by":"publisher","first-page":"7441","DOI":"10.18632\/oncotarget.7465","volume":"8","author":"F Ricci","year":"2017","unstructured":"Ricci F, Fratelli M, Guffanti F, Porcu L, Spriano F, Dell\u2019Anna T, Fruscio R, Damia G (2017) Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy. Oncotarget 8:7441\u20137451","journal-title":"Oncotarget"},{"key":"69_CR47","doi-asserted-by":"publisher","first-page":"20170065","DOI":"10.1098\/rstb.2017.0065","volume":"373","author":"P Samuel","year":"2018","unstructured":"Samuel P, Mulcahy LA, Furlong F, McCarthy HO, Brooks SA, Fabbri M, Pink RC, Carter DRF (2018) Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells. Philos Trans R Soc Lond B Biol Sci 373:20170065","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"69_CR48","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tcb.2014.12.006","volume":"25","author":"L Seguin","year":"2015","unstructured":"Seguin L, Desgrosellier JS, Weis SM, Cheresh DA (2015) Integrins and cancer: regulators of cancer stemness, metastasis, and drug resistance. Trends Cell Biol 25:234\u2013240","journal-title":"Trends Cell Biol"},{"key":"69_CR49","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/jcm5020017","volume":"5","author":"BN Smith","year":"2016","unstructured":"Smith BN, Bhowmick NA (2016) Role of EMT in metastasis and therapy resistance. J Clin Med 5:17","journal-title":"J Clin Med"},{"key":"69_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aav3235","volume":"5","author":"M Sonego","year":"2019","unstructured":"Sonego M, Pellarin I, Costa A, Vinciguerra GLR, Coan M, Kraut A, D\u2019Andrea S, Dall\u2019Acqua A, Castillo-Tong DC, Califano D et al (2019) USP1 links platinum resistance to cancer cell dissemination by regulating Snail stability. Sci Adv 5:eaav3235","journal-title":"Sci Adv"},{"key":"69_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07005-1","volume":"7","author":"M Sonego","year":"2017","unstructured":"Sonego M, Pellizzari I, Dall\u2019Acqua A, Pivetta E, Lorenzon I, Benevol S, Bomben R, Spessotto P, Sorio R, Gattei V et al (2017) Common biological phenotypes characterize the acquisition of platinum-resistance in epithelial ovarian cancer cells. Sci Rep 7:7104","journal-title":"Sci Rep"},{"key":"69_CR52","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/cells9010006","volume":"9","author":"M Sonego","year":"2020","unstructured":"Sonego M, Poletto E, Pivetta E, Nicoloso MS, Pellicani R, Rampioni Vinciguerra GL, Citron F, Sorio R, Mongiat M, Baldassarre G (2020) TIMP-1 is overexpressed and secreted by platinum resistant epithelial ovarian cancer. Cells Cells 9:6","journal-title":"Cells Cells"},{"key":"69_CR53","doi-asserted-by":"crossref","unstructured":"Spessotto P, Lacrima K, Nicolosi PA, Pivetta E, Scapolan M, Perris R (2009) Fluorescence-based assays for in vitro analysis of cell adhesion and migration. In: Even-Ram S, Artym V (eds) Extracellular matrix protocols. Humana Press, Totowa, pp 221\u2013250","DOI":"10.1007\/978-1-59745-413-1_16"},{"key":"69_CR54","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/ncb1734","volume":"10","author":"I Taddei","year":"2008","unstructured":"Taddei I, Deugnier M-A, Faraldo MM, Petit V, Bouvard D, Medina D, F\u00e4ssler R, Thiery JP, Glukhova MA (2008) Beta1 integrin deletion from the basal compartment of the mammary epithelium affects stem cells. Nat Cell Biol 10:716\u2013722","journal-title":"Nat Cell Biol"},{"key":"69_CR55","doi-asserted-by":"publisher","first-page":"3964","DOI":"10.1038\/onc.2017.5","volume":"36","author":"D Thaper","year":"2017","unstructured":"Thaper D, Vahid S, Nip KM, Moskalev I, Shan X, Frees S, Roberts ME, Ketola K, Harder KW, Gregory-Evans C et al (2017) Targeting Lyn regulates Snail family shuttling and inhibits metastasis. Oncogene 36:3964\u20133975","journal-title":"Oncogene"},{"key":"69_CR56","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10555-013-9456-2","volume":"33","author":"B Thibault","year":"2014","unstructured":"Thibault B, Castells M, Delord J-P, Couderc B (2014) Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition. Cancer Metastasis Rev 33:17\u201339","journal-title":"Cancer Metastasis Rev"},{"key":"69_CR57","first-page":"3974","volume":"17","author":"L Wei","year":"2019","unstructured":"Wei L, Yin F, Chen C, Li L (2019) Expression of integrin \u03b1-6 is associated with multi drug resistance and prognosis in ovarian cancer. Oncol Lett 17:3974\u20133980","journal-title":"Oncol Lett"},{"key":"69_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z (2020) Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun 11:5120","journal-title":"Nat Commun"},{"key":"69_CR59","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3389\/fgene.2020.00705","volume":"11","author":"A Wu","year":"2020","unstructured":"Wu A, Zhang S, Liu J, Huang Y, Deng W, Shu G, Yin G (2020) Integrated analysis of prognostic and immune associated integrin family in ovarian cancer. Front Genet 11:705","journal-title":"Front Genet"},{"key":"69_CR60","doi-asserted-by":"publisher","first-page":"2204940","DOI":"10.1080\/01443615.2023.2204940","volume":"43","author":"M Zhang","year":"2023","unstructured":"Zhang M, Bao Y, Zhang H, Li D, Mei X, Cheng X (2023) Efficacy and safety of intraperitoneal bevacizumab combined with hyperthermic intraperitoneal chemotherapy in the treatment of patients with ovarian cancer and peritoneal effusion and the effect on serum lncRNA H19 and VEGF levels. J Obstet Gynaecol 43:2204940","journal-title":"J Obstet Gynaecol"},{"key":"69_CR61","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1016\/j.ejca.2013.03.014","volume":"49","author":"H Zheng","year":"2013","unstructured":"Zheng H, Li W, Wang Y, Liu Z, Cai Y, Xie T, Shi M, Wang Z, Jiang B (2013) Glycogen synthase kinase-3 beta regulates Snail and \u03b2-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer. Eur J Cancer 49:2734\u20132746","journal-title":"Eur J Cancer"},{"key":"69_CR62","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/ncb1173","volume":"6","author":"BP Zhou","year":"2004","unstructured":"Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M, Hung M-C (2004) Dual regulation of Snail by GSK-3\u03b2-mediated phosphorylation in control of epithelial\u2013mesenchymal transition. Nat Cell Biol 6:931\u2013940","journal-title":"Nat Cell Biol"}],"updated-by":[{"DOI":"10.1038\/s44321-024-00099-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000}}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00069-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-024-00069-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-024-00069-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:03:32Z","timestamp":1785863012000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-024-00069-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,16]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1038\/s44321-024-00069-3","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,24]]},"assertion":[{"value":"3 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2024","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s44321-024-00099-x","URL":"https:\/\/doi.org\/10.1038\/s44321-024-00099-x","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"7"}}